N

Nanjing Vazyme Biotech Co Ltd
SSE:688105

Watchlist Manager
Nanjing Vazyme Biotech Co Ltd
SSE:688105
Watchlist
Price: 21.41 CNY 1.71%
Market Cap: 8.5B CNY

Intrinsic Value

The intrinsic value of one Nanjing Vazyme Biotech Co Ltd stock under the Base Case scenario is 17.47 CNY. Compared to the current market price of 21.41 CNY, Nanjing Vazyme Biotech Co Ltd is Overvalued by 18%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
17.47 CNY
Overvaluation 18%
Intrinsic Value
Price
N
Worst Case
Base Case
Best Case

Valuation History
Nanjing Vazyme Biotech Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about Nanjing Vazyme Biotech Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Nanjing Vazyme Biotech Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Nanjing Vazyme Biotech Co Ltd.

Explain Valuation
Compare Nanjing Vazyme Biotech Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Nanjing Vazyme Biotech Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Nanjing Vazyme Biotech Co Ltd

Current Assets 3.7B
Receivables 510m
Other Current Assets 3.1B
Non-Current Assets 1.4B
Long-Term Investments 66m
PP&E 638m
Intangibles 219m
Other Non-Current Assets 427m
Current Liabilities 980m
Accounts Payable 67m
Accrued Liabilities 79m
Short-Term Debt 696m
Other Current Liabilities 138m
Non-Current Liabilities 183m
Long-Term Debt 126m
Other Non-Current Liabilities 57m
Efficiency

Free Cash Flow Analysis
Nanjing Vazyme Biotech Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Nanjing Vazyme Biotech Co Ltd

Revenue
1.3B CNY
Cost of Revenue
-418.2m CNY
Gross Profit
926.2m CNY
Operating Expenses
-1B CNY
Operating Income
-119.8m CNY
Other Expenses
90.1m CNY
Net Income
-29.6m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Nanjing Vazyme Biotech Co Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Gross Margin is Increasing
Low 3Y Average Net Margin
37/100
Profitability
Score

Nanjing Vazyme Biotech Co Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Nanjing Vazyme Biotech Co Ltd's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Short-Term Solvency
Low D/E
78/100
Solvency
Score

Nanjing Vazyme Biotech Co Ltd's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Nanjing Vazyme Biotech Co Ltd

Wall Street analysts forecast Nanjing Vazyme Biotech Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Nanjing Vazyme Biotech Co Ltd is 28.76 CNY with a low forecast of 27.27 CNY and a high forecast of 30.86 CNY.

Lowest
Price Target
27.27 CNY
27% Upside
Average
Price Target
28.76 CNY
34% Upside
Highest
Price Target
30.86 CNY
44% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Nanjing Vazyme Biotech Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Nanjing Vazyme Biotech Co Ltd stock?

The intrinsic value of one Nanjing Vazyme Biotech Co Ltd stock under the Base Case scenario is 17.47 CNY.

Is Nanjing Vazyme Biotech Co Ltd stock undervalued or overvalued?

Compared to the current market price of 21.41 CNY, Nanjing Vazyme Biotech Co Ltd is Overvalued by 18%.

Back to Top